What is Targeted Therapy?
Targeted therapy is a modern and precise form of cancer treatment that uses drugs designed to “target” specific molecules that are involved in the growth, progression, and spread of cancer cells. These molecules are often the result of genetic mutations or other abnormalities found within the cancer cells but not in normal, healthy cells. Unlike traditional chemotherapy, which attacks all rapidly dividing cells in the body, targeted therapies are more like “smart drugs” that act on specific, pre-identified targets. This precision often leads to a different and sometimes more manageable side effect profile. Over the last two decades, targeted therapy has become a standard and highly effective treatment for many types of cancer, transforming the outlook for numerous patients.
The Importance of Biomarkers and Molecular Testing
The central concept of targeted therapy is that a specific target must be identified before the treatment can be used. This requires a process called molecular testing, or biomarker testing. A sample of the patient’s tumor tissue, usually obtained from a biopsy or surgery, is sent to a pathology lab for detailed analysis. The lab tests the tumor’s DNA and proteins to look for specific “biomarkers”—the molecular targets that the drugs are designed to attack.
Examples of common biomarkers include:
- EGFR mutations in non-small cell lung cancer.
- HER2 amplification in breast and stomach cancers.
- BRAF mutations in melanoma and other cancers.
- KIT mutations in gastrointestinal stromal tumors (GIST).
In Turkish oncology centers, performing these molecular tests on a patient’s tumor is a standard and essential step in the diagnostic process for many cancers. The results of these tests are critical, as they provide the medical oncologist with a roadmap to determine if a specific targeted therapy is a suitable option for that individual patient. Without a matching target, a targeted therapy drug will not be effective.
How Targeted Therapies Work
Targeted therapy drugs can work in several different ways, depending on the specific target they are designed to block.
- Blocking Growth Signals: Many cancer cells have mutations that cause them to produce or respond to proteins that signal them to grow and divide uncontrollably. Targeted therapies can block these signals, effectively turning off the “on switch” that drives the cancer’s growth. Drugs that do this are often called “inhibitors” (e.g., kinase inhibitors).
- Interfering with Blood Vessel Formation (Anti-angiogenesis): Tumors need to form new blood vessels to get the oxygen and nutrients they need to grow beyond a certain size. This process is called angiogenesis. Some targeted therapies, known as angiogenesis inhibitors, work by blocking the proteins (like VEGF) that tumors use to create this new blood supply, effectively starving the tumor.
- Delivering Cell-Killing Substances: Some targeted therapies consist of a monoclonal antibody (a lab-made protein that can find and attach to a specific target on a cancer cell) joined to a powerful chemotherapy drug or radioactive particle. This combination, called an antibody-drug conjugate (ADC), acts like a guided missile, delivering the toxic substance directly to the cancer cells while sparing most healthy cells.
The Role of the Medical Oncologist in Turkey
The medical oncologist is the specialist who manages a patient’s treatment with targeted therapy in Turkey. Their expertise is crucial in navigating this complex and personalized area of oncology.
Their responsibilities include:
- Ordering and Interpreting Molecular Tests: The oncologist ensures the correct biomarker tests are performed on the tumor tissue and interprets the results to guide treatment decisions.
- Treatment Selection: Based on the test results, cancer type, and international guidelines, they select the appropriate targeted therapy drug and treatment plan.
- Managing Treatment: They oversee the administration of the therapy and monitor the patient for side effects and treatment response.
- Adapting the Plan: Cancer can sometimes become resistant to a targeted therapy. The oncologist is responsible for monitoring for resistance and adjusting the treatment plan if necessary, which may involve switching to a different therapy.
How is Targeted Therapy Administered?
The administration of targeted therapy can be different from other cancer treatments.
- Oral Medications: One of the most significant differences is that many targeted therapy drugs are pills or capsules that can be taken orally at home. This offers patients greater convenience and independence. However, it is critically important for patients to adhere strictly to the prescribed dose and schedule, as these are powerful medications.
- Intravenous (IV) Infusions: Some targeted therapies, particularly those based on monoclonal antibodies, are administered as an intravenous infusion in a hospital’s outpatient infusion unit. These infusions are typically given on a regular schedule, such as once every few weeks.
Side Effects of Targeted Therapy
Because targeted therapies are more precise than chemotherapy, they do not typically cause the same side effects like widespread hair loss or severe bone marrow suppression. However, they are not without side effects. The side effects of a targeted therapy are directly related to the specific molecule or pathway it is blocking.
Common side effects can include:
- Skin problems: Rashes, acne-like breakouts, dry skin, and nail changes are very common with drugs that target the EGFR pathway.
- Diarrhea: This is a frequent side effect of many different targeted therapy drugs.
- High blood pressure: This is commonly associated with angiogenesis inhibitors.
- Fatigue: A feeling of tiredness is common across many cancer treatments, including targeted therapy.
- Liver problems: Some drugs can affect liver function, which is monitored with regular blood tests.
Oncology teams in Turkey are highly experienced in educating patients about these potential side effects and providing proactive strategies and medications to manage them effectively.
Frequently Asked Questions
1. How is targeted therapy different from chemotherapy?
The main difference is their mechanism of action. Chemotherapy is a cytotoxic agent that kills all rapidly dividing cells, both cancerous and healthy. Targeted therapy is more precise; it is designed to interfere with specific molecules or pathways that are uniquely involved in the growth and survival of cancer cells. This often results in a different side effect profile.
2. How do doctors in Turkey decide which targeted therapy drug to use?
The decision is based almost entirely on the results of molecular (biomarker) testing performed on a sample of the patient’s tumor. The tests identify the specific genetic mutations or protein abnormalities that are driving the cancer. The doctor then matches these findings to a targeted therapy drug that is known to be effective against that specific target.
3. Are all targeted therapy drugs taken as pills?
No. While many modern targeted therapies are oral medications that patients can take at home, many others, especially those that are monoclonal antibodies, must be administered as an intravenous (IV) infusion in a hospital’s infusion center.
4. Do targeted therapies have side effects?
Yes. Although the side effects are generally different from those of chemotherapy, targeted therapies can still cause significant side effects. The specific side effects depend on the target the drug is blocking. Common examples include skin rashes, diarrhea, and high blood pressure. It is important to discuss potential side effects with your medical oncologist.
5. Is targeted therapy considered a “cure” for cancer?
For most advanced or metastatic cancers, targeted therapies are not a cure. However, they can be exceptionally effective at controlling the cancer, often for long periods, shrinking tumors, relieving symptoms, and significantly extending a patient’s life while maintaining a good quality of life. In some specific situations, such as when used as an adjuvant therapy after surgery, they can help increase the chance of a cure.
6. What is a “kinase inhibitor”?
This is a common term for a large class of targeted therapy drugs. Kinases are proteins inside cells that act as “on/off” switches for many cellular processes, including cell growth and division. In many cancers, a mutation causes a specific kinase to be permanently “switched on,” leading to uncontrolled growth. A kinase inhibitor is a drug designed to block that specific kinase, turning off the signal and stopping the cancer’s growth.
7. Can targeted therapy be used with other cancer treatments?
Yes, very often. Targeted therapy can be combined with chemotherapy, radiation therapy, or immunotherapy. The specific combination depends on the type of cancer and the treatment goal. For example, a targeted drug might be given alongside chemotherapy to attack the cancer from two different angles.
